Preventing and Treating Childhood Mental Disorders: Effective Interventions by Schwartz, C et al.
Preventing and Treating
Childhood Mental Disorders: 
Effective Interventions 








Preventing and Treating Childhood Mental Disorders: Effective Interventions Page 2 of 43 










We celebrate the Indigenous Peoples on whose traditional 






Citing This Report 
Schwartz, C., Yung, D., Barican, J., & Waddell, C. (2020). Preventing and Treating Childhood Mental Disorders: 






The Child and Youth Mental Health Policy Branch of the British Columbia (BC) Ministry of Children and 
Family Development funded this project, with co-sponsorship from the BC Ministry of Mental Health and 
Addictions. We thank the Policy Advisory Committee for this project, who provided valuable input. We 





Children’s Health Policy Centre 
Faculty of Health Sciences, Simon Fraser University 
2435 – 515 West Hastings Street, Vancouver, BC  V6B 5K3 
778.782.7775 | childhealthpolicy.ca  
	
 
Preventing and Treating Childhood Mental Disorders: Effective Interventions Page 3 of 43 







Executive Summary  ......................................................................................................................................  4 
 
1.  Background  ................................................................................................................................................  5 
 
2.  Methods  ........................................................................................................................................................  6 
 
3.  Findings on Effective Interventions .................................................................................................  8 
3.1   Anxiety Disorders ..............................................................................................................................  9 
3.2   Attention-Deficit/Hyperactivity Disorder .................................................................................... 10 
3.3   Oppositional Defiant Disorder ....................................................................................................... 11 
3.4     Conduct Disorder  ............................................................................................................................ 11 
3.5   Substance Use Disorders ................................................................................................................. 13 
3.6   Depression ........................................................................................................................................... 14 
3.7   Autism Spectrum Disorder .............................................................................................................. 15 
3.8   Obsessive-Compulsive Disorder .................................................................................................... 16 
3.9   Bipolar Disorder ................................................................................................................................. 16 
3.10  Eating Disorders ................................................................................................................................. 17 
3.11  Posttraumatic Stress Disorder ........................................................................................................ 18 
3.12  Schizophrenia ...................................................................................................................................... 19 
 
4.  Conclusions  ................................................................................................................................................ 20 
 4.1     Prevention ........................................................................................................................................... 20 
 4.2     Psychosocial Treatments ................................................................................................................. 20 
 4.3     Medications ......................................................................................................................................... 21 
 4.4     Moving Forward ................................................................................................................................. 22 
 
References  .......................................................................................................................................................... 23 
 




Preventing and Treating Childhood Mental Disorders: Effective Interventions Page 4 of 43 






Mental health, or social and emotional wellbeing, is a crucial resource for all children — enabling them to 
flourish, meet their potential and be resilient in the face of adversity. Yet based on high-quality 
epidemiological studies, an estimated 12.7% of children — or nearly 95,000 children aged four to 18 years 
in British Columbia — will experience mental disorders causing significant symptoms and impairment at 
any given time. All children with mental disorders require effective treatments, and many additional 
children would benefit from effective prevention programs.  
 
To inform policymaking to address these needs, this report summarizes the best available research evidence 
on effective interventions for preventing and treating 12 of the most common mental disorders (or groups 
of disorders) affecting children aged 18 years or younger. These disorders include: 1) anxiety disorders;      
2) attention-deficit/hyperactivity disorder (ADHD); 3) oppositional defiant and 4) conduct disorders;        
5) substance use disorders (SUDs); 6) depression; 7) autism spectrum disorder; 8) obsessive-compulsive 
disorder (OCD); 9) bipolar disorder; 10) eating disorders; 11) posttraumatic stress disorder (PTSD); and                
12) schizophrenia.  
 
Our systematic review identified 113 randomized controlled trials (RCTs) and six systematic reviews that 
met inclusion criteria. Intervention effectiveness was defined as two or more RCT evaluations showing 
statistically-significant reductions in disorder diagnoses and/or symptoms for children. Applying these 
criteria, we identified effective prevention interventions for eight of the most common childhood mental 
disorders and effective treatments for all 12. However, estimates from high-quality epidemiological studies 
indicate that an estimated 55.8% of children with mental disorders — or nearly 53,000 children in BC — do 
not receive services for these disorders in a typical year. These estimates suggest stark service shortfalls, even 
apart from the question of effective services.  
 
To address these high levels of need, a first step is adopting a comprehensive population health strategy for 
children’s mental health. Such a strategy includes:  
1)  Addressing social determinants and reducing avoidable childhood adversities that contribute to the 
development of mental health problems  
2)  Providing effective prevention programs, such as those reported here, for children at risk 
3)  Providing effective treatments, such as those reported here, for all children with disorders, and  
4)  Monitoring needs and outcomes over time to evaluate and improve intervention efforts.  
 
Vigorous central leadership is also required to ensure that such a plan is sustained over time, accompanied 
by adequate and dedicated children’s mental health budgets, and coordinated across all relevant sectors 
within government. BC’s children will benefit, as will everyone, if children’s mental health is made a high 
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1.  Background 
 
1.1 The Importance of Children’s Mental Health 
 
Mental health, or social and emotional wellbeing, is a crucial resource for all children in British Columbia 
(BC) — enabling them to flourish, meet their potential and be resilient in the face of adversity. For some 
children, however, development is interrupted by mental disorders. If not prevented or treated early, these 
disorders can lead to serious ongoing distress, symptoms and impairment for individual children, as well as 
distress and costs for their families — and substantial associated costs for society, particularly when disorders 
continue into adulthood.1 An estimated 12.7% of children aged 18 years or younger (or 94,800 in BC) will 
meet the criteria for a mental disorder at any given time, including having both symptoms and impairment 
and therefore needing treatment.2 Yet an estimated 55.8% of children with mental disorders (or 52,900 in 
BC) do not receive services for these disorders in a typical year.2 Ensuring the timely availability of effective 
prevention and treatment interventions for all children in need is a crucial first step in addressing these 
service gaps. At the same time, policymakers require high-quality research evidence on such interventions to 
guide program planning and public investments. 
 
________________________________________________________________________ 
Mental health, or social and emotional wellbeing,  
is a crucial resource for all children in British Columbia. 
________________________________________________________________________ 
 
1.2  Purpose of This Research Report  
  
To inform policymaking in BC, this report summarizes the best available research evidence on effective 
interventions for preventing and treating 12 of the most common mental disorders occurring in children 
aged 18 years or younger. These disorders include: 1) anxiety disorders; 2) attention-deficit/hyperactivity 
disorder (ADHD); 3) oppositional defiant and 4) conduct disorders; 5) substance use disorders (SUDs);      
6) depression; 7) autism spectrum disorder; 8) obsessive-compulsive disorder (OCD); 9) bipolar disorder; 
10) eating disorders; 11) posttraumatic stress disorder (PTSD); and 12) schizophrenia.  
 
Prevention interventions are programs that intervene before mental disorders develop. These programs 
typically aim to address underlying causes such as avoidable adversities that can lead to the development of 
mental disorders; they may be universal (offered to all children and/or families) or targeted (offered to those 
at risk). Meanwhile, treatment interventions include both psychosocial programs and medications.  
 
The overarching goal is to assist in ensuring that all children in need in BC can access effective mental 
health interventions. The policy context is that of the BC Government’s ongoing commitment to 
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2.  Methods 
To compile the best available research evidence, we used systematic review methods adapted from the 
Cochrane Collaboration and Evidence-Based Mental Health to identify relevant randomized controlled trials 
(RCTs). We searched standard databases including Campbell, Cochrane, CINAHL, ERIC, Medline, 
PsycINFO and Web of Science for RCTs and/or systematic reviews. We built on work done for our 
previous peer-reviewed academic publications and our Children’s Mental Health Research Quarterly. To ensure 
we included the most recent evidence, we conducted additional updating searches to identify new RCTs 
and systematic reviews for selected disorders where needed.   
 
To be included, RCTs and systematic reviews had to be published in peer-reviewed journals. The 
interventions they assessed had to be delivered to children (aged 18 years or younger) and/or their families 
living in high-income countries (for comparability to BC). Study attrition had to be ≤20% or intention-to-
treat analyses had to be performed. For most RCTs, we required two or more informant sources (e.g., child, 
parent and/or teacher). Nevertheless, to ensure comprehensiveness we made exceptions for RCTs assessing 
psychosocial interventions aimed at preventing ADHD, preventing or treating SUDs and treating bipolar 
disorder because few included two or more sources.  
 
For psychosocial intervention studies, we required at least one informant source to be “blinded.” In other 
words, child and/or family allocations to intervention or comparison groups were concealed from the 
assessors. The exceptions were RCTs on ADHD and PTSD prevention interventions and on psychosocial 
SUD interventions, because few included blinding. We also required follow-up of at least three months for 
all psychosocial interventions, with the exception of studies assessing OCD treatments because few tracked 
outcomes beyond the end of treatment.  
 
For medication studies, we required double-blinding, that is, of both participants and assessors, as well as 
placebo controls and a comprehensive assessment of adverse events. The one exception was medications for 
schizophrenia, where we accepted studies directly comparing two medications without using a placebo, 
provided that one of the medications had already shown benefits in young people in a double-blind, 
placebo-controlled RCT. We excluded medications where the adverse events were particularly troubling and 
likely to outweigh potential benefits. 
 
For disorders where research evidence was particularly abundant, we added criteria to ensure that we 
presented the best available evidence. For example, we required diagnostic outcomes for psychosocial 
prevention interventions for depression and required one-year follow-up for SUD prevention programs.  
 
For all RCTs, we extracted outcomes for both diagnoses and core symptoms of the disorder, where possible. 
We classified measures of overall functioning as symptom measures. We reported outcomes at final follow-
up, noting that RCTs vary considerably regarding this parameter. For example, most medication studies 
typically stopped at post-test, after children had been taking medications just several weeks, while many 
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psychosocial intervention studies followed children longer term, for months or years after the interventions 
ended. 
  
For this report, for an intervention to be deemed effective, two or more RCTs conducted with children had 
to show statistically-significant reductions (p < .05) in disorder diagnoses and/or symptoms using reliable 
and valid measures. Throughout our process, all steps were conducted and verified by two or more team 
members, resolving any differences by consensus. The Appendix provides detailed information on our 
findings for each disorder. 
 
This report is based on research evidence drawn from rigorous, high-quality studies evaluating intervention 
effectiveness, namely RCTs. RCTs are regarded as the best evidence for assessing the impact of health-
related interventions.3–4 We nevertheless acknowledge that this methodology has limitations — including 







We identified effective prevention interventions 
 for eight of the most common childhood mental disorders  
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3.  Findings 
 
We identified effective treatments for all 12 childhood disorders covered in this review — as well as effective 
prevention interventions for eight. Regarding treatment, for seven disorders (anxiety disorders, ADHD, 
oppositional defiant and conduct disorders, depression, OCD and bipolar disorder) both psychosocial 
interventions and medications met our inclusion criteria. For four disorders (SUDs, autism spectrum 
disorder, eating disorders and PTSD) only psychosocial interventions met criteria. For the remaining 
disorder (schizophrenia) only medications met criteria.   
 
We have presented our findings based on prevalence, starting with the most common, namely anxiety 
disorders.2 We have also provided estimates of the number of BC children affected by each disorder at any 
given time, based on applying prevalence data to Statistics Canada population data.7 (“Children” refer to 
those age 18 years or younger; “parent” refers to all individuals caring for children, including foster 
parents.) 
 
We identified both universal and targeted prevention interventions. Universal prevention programs are 
delivered to entire populations, such as every student in a school, while targeted prevention programs are 
directed to children and families identified as being at risk, such as those experiencing disorder symptoms 
but not meeting full diagnostic criteria.  
 
We have presented data on interventions for all anxiety disorders together because similar interventions 
were used for all. We have presented data on interventions for oppositional defiant and conduct disorders 
together for the same reason. 
 
All effective interventions had at least two RCTs supporting their use with young people. For most 
disorders, we have presented data from the original RCTs. We have summarized these data in text, while 
also providing greater detail on the 113 RCTs that met our inclusion criteria in the Appendix. We have 
also included RCT data contained in systematic reviews for the treatment of five disorders. We did this 
because most of these systematic reviews included meta-analyses providing additional information, such as 
relative efficacy or cost-effectiveness comparisons. Where possible, we have also provided information on 
the effect sizes of interventions. Effect sizes detail the degree of difference that the intervention made in 




British Columbia’s children will benefit, as will everyone,  
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Four cognitive-behavioural therapy (CBT) interventions, evaluated in five RCTs, proved effective in 
preventing anxiety diagnoses and/or symptoms with children.8–13 One intervention was delivered 
universally while three were targeted. CBT typically involved educating children and families about anxiety, 
coaching children to reduce physical symptoms of anxiety using techniques such as deep breathing, teaching 
children to challenge unrealistic and unhelpful anxious thinking, and encouraging children to practice 
being in fear-provoking situations while managing their anxiety.14 (Because very similar CBT techniques are 
used for preventing and treating each anxiety disorder, we review all anxiety disorders together.)   
 
Notably, CBT prevention programs were effective in a variety of formats including teaching parents to 
provide CBT to their young children, delivering CBT to groups of children or to individual families, or via 
self-delivery. CBT was effective at preventing anxiety symptoms across developmental periods with children 
from four to 17 years. In addition to all reported findings being statistically significant, CBT also showed 
large effect sizes. For example, one RCT found that the odds of being diagnosed with an anxiety disorder 
was more than eight times lower when young people received CBT.11–12 
 
Psychosocial Treatment  
 
CBT also proved highly effective for treating anxiety disorders — with nine programs, assessed in 12 RCTs, 
significantly reducing the number of children with anxiety disorders and/or anxiety symptoms.15–27  As with 
prevention, CBT was effective in a variety of formats including teaching parents to provide CBT to their 
young children, delivering CBT to children individually or in groups, or via self-delivery. Also similar to 
prevention, CBT was effective with children from two to 17 years. Where effect sizes were calculated, most 
were substantial. When young people received CBT, the odds of no longer meeting diagnostic criteria for 
any anxiety disorder was 2.5 to 8.5 times higher across three RCTs,18, 26–27 while the odds of no longer 




Fluoxetine and sertraline effectively reduced anxiety symptoms in two RCTs each.28–31 In one trial, 
fluoxetine also significantly reduced the number of children meeting criteria for their primary anxiety 
disorder.28 One RCT calculated effects sizes, finding that young people prescribed sertraline had 3.9 times 
lower odds of continuing to have anxiety symptoms.31 However, both medications produced adverse events. 
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Table 1 summarizes the anxiety intervention findings as well as the prevalence for anxiety disorders and the 
estimated number of BC children affected at any given time. The Appendix gives more details on the 21 
RCTs evaluating anxiety interventions. 
 
Table 1. Effective Anxiety Disorder Interventions  
Anxiety Disorders 5.2% or 38,800 (4–18 years) in BC 
Prevention: Cognitive-behavioural therapy (5 RCTs)8–13 
Treatment (Psychosocial): Cognitive-behavioural therapy (12 RCTs)15–27 
Treatment (Medication): Fluoxetine (2 RCTs)28–29 + sertraline (2 RCTs)30–31 
 
 




Three targeted parent training interventions, evaluated in four RCTs, proved effective in reducing 
symptoms of ADHD with at-risk children.32–38 (We use the phrase “parent training” because it the term 
commonly used in the research literature for programs focusing on teaching parents specific skills to help 
with children’s behavioural challenges.) Programs typically focused on teaching parents to encourage their 
child’s positive behaviour by providing attention and praise and by discouraging challenging behaviours, 
including ignoring minor misbehaviours.39 All three programs focused on parents with young children, 
including one that began during pregnancy. As well, all were delivered in groups. The Incredible Years 
program stood out by reducing ADHD symptoms across two RCTs.32–33 
 
Psychosocial Treatment  
 
Three parent training programs also proved successful in reducing ADHD symptoms or diagnoses in three 
RCTs. These programs were effective in varying formats including delivery in groups, to individual parents 
and via self-delivery. The programs were also effective for children from three to 18 years.26, 40–41 The 
Strongest Families program stood out by reducing ADHD diagnoses. Specifically, the odds of children 
continuing to have an ADHD diagnosis five months after their parents completed the program was 2.7 
times lower.26    
 
As well, two multicomponent interventions reduced ADHD symptoms with school age children.42–43 Both 
combined parent training with child behaviour therapy and child social skills training. Behaviour therapy 
involved rewarding children for positive behaviours, while social skills training involved teaching children 
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Methylphenidate, dextroamphetamine and atomoxetine were effective in significantly reducing ADHD 
symptoms based on a meta-analysis of 64 RCTs.44 A cost-effectiveness analysis favoured methylphenidate 
and dextroamphetamine given that they were less expensive while being as effective as atomoxetine. 
However, all medications produced adverse events, including decreased appetite, insomnia and stomach-
aches, without significant differences between them. Another meta-analysis of 26 RCTs found that 
methylphenidate used alone or in combination with psychosocial treatments was significantly more effective 
than psychosocial treatments alone.45  
 
Table 2 summarizes the ADHD findings as well as the prevalence for ADHD and the estimated number of 
BC children affected at any given time. The Appendix gives more details on the 11 RCTs and the two meta-
analyses evaluating the ADHD interventions. 
 
Table 2. Effective ADHD Interventions  
ADHD 3.7% or 27,600 (4–18 years) in BC 
Prevention: Parent training (4 RCTs)32–38 
Treatment (Psychosocial): Parent training (3 RCTs)26, 40–41 + multicomponent interventions (2 RCTs in 
total)42–43 with each including behaviour therapy, parent training + social skills training 








Six parent training programs, evaluated in 10 RCTs, proved effective in preventing symptoms of 
oppositional defiant and conduct disorders — when delivered universally and to at-risk children.46–58 
Programs typically focused on teaching parents to encourage their child’s positive behaviour by providing 
attention and praise and managing challenging behaviours, including by ignoring minor misbehaviours.59 
These parent training programs were delivered both in groups and individually, including using self-
directed formats. While most participating parents had young children, typically preschool age, Nurse-
Family Partnership began prenatally while Parent-Management Training included parents of children up to 
age 10. Among these programs, Triple P and Incredible Years stood out by showing success across multiple 
RCTs.46, 48, 51–52, 57–58 
 
Five other programs, evaluated in five RCTs, also proved successful in reducing diagnosis and/or symptoms 
— by using either single interventions or multicomponent interventions. These included combinations of 
parent training, behaviour therapy, social skills training, enriched school curricula, and/or parent-school 
collaborations.60–65 Behaviour therapy involved rewarding children for their positive behaviours while social 
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skills training taught children strategies to improve their relationships.62 The enriched school curricula 
focused on building children’s skills to promote school success, including self-control and critical thinking, 
while parent-school collaborations aimed to increase communication between parents and teachers.62 
Notably, all five programs were delivered in educational settings, beginning in grade one or earlier. Two 
programs — Good Behavior Game and Fast Track — stood out by showing very long-term success, including 
reducing antisocial personality disorder diagnoses in adulthood up to 14 years after the programs ended.60, 63  
 
Psychosocial Treatment  
 
Two parent training interventions, evaluated in two RCTs, successfully reduced symptoms of behaviour 
disorders in young children.66–68 For example, children whose parents who participated in Incredible Years 
had five times higher odds of not meeting diagnostic criteria for oppositional defiant disorder nearly eight 
years after the study ended, compared with children of parents who did not participate in the program.66 As 
well, three youth-oriented interventions showed success in four RCTs.69–72 One used cognitive-behavioural 
therapy (CBT) to teach young people strategies for coping and solving problems.69 The two other programs 
used parent training and youth social skills training or CBT, delivering parent and youth components 




Risperidone reduced behaviour symptoms according to three RCTs.74–76 However, adverse effects, including 
fatigue and weight gain, were frequent.74–76  
 
Table 3 summarizes the intervention findings as well as the prevalence for oppositional defiant and conduct 
disorders and the estimated number of BC children affected at any given time. The Appendix gives more 
details on the 23 RCTs evaluating the oppositional defiant and conduct disorder interventions. 
 
Table 3. Effective Oppositional Defiant and Conduct Disorder Interventions  
Oppositional Defiant Disorder                                                         3.3% or 24,600 (4–18 years) in BC 
Conduct Disorder 1.3% or 9,700 (4–18 years) in BC 
Prevention: Parent training (10 RCTs)46–58 + multicomponent interventions (5 RCTs in total with 1 RCT 
evaluating a single component)60–65 including combinations of behaviour therapy, enriched school curricula, 
parent-school collaborations, parent training +/or social skills training. 
Treatment (Psychosocial): Parent training (2 RCTs)66–68 + multicomponent interventions (4 RCTs in total 
with 1 RCT evaluating a single component)69–73 including combinations of cognitive-behavioural therapy, parent 
training +/or social skills training 
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Six universal programs, evaluated in six RCTs, proved effective in reducing substance use. All were 
multicomponent interventions including combinations of resistance skills, parent training, child education, 
child social skills training, and child-and-family communication skills training.77–86 Resistance skills focused 
on teaching young people to strategies to withstand peer pressure.87 Parent training focused on enhancing 
skills including setting limits, rewarding adaptive behaviours and providing consequences for children’s 
substance use.84, 88 Child education involved teaching young people about the effects of substance use and 
correcting misbeliefs.85 Child social skills training included teaching young people skills for establishing and 
maintaining positive peer relationships.88 Communication skills training focused on improving dialogues 
between children and parents.84, 89  Five programs were delivered to groups of children in schools, typically 
between grades six and nine, while one program used self-directed delivery with daughters and mothers.84 
Among the six programs, Unplugged stood out by showing success in two RCTs, with comparison youth 
having 1.3 times greater odds of drunkenness and 1.8 times greater odds of cannabis use in the past 
month.85–86 
 
Three targeted prevention programs, evaluated in four RCTs, also proved effective in reducing substance 
use using either a single intervention or a multicomponent intervention.88, 90–94 These interventions 
included motivational interviewing, cognitive-behavioural therapy (CBT), social skills training and 
education. Motivational interviewing included encouraging young people to examine the negative 
consequences of substance use as well as potential benefits for reducing it.95 CBT included examining 
triggers for substance use, challenging beliefs that supported substance use and learning to avoid high risk 
situations. Of the three programs, two were delivered in groups and one was delivered individually — with 
young people who ranged from 10 to 18 years. The Preventure program — which was delivered in schools — 
stood out by showing success in two RCTs.92, 94 As well, its effect size was moderately high, with one RCT 
showing that comparison youth had 1.4 times greater odds of showing symptoms of problematic alcohol 
use. 
 
Psychosocial Treatment  
 
Four programs, evaluated in six RCTs, proved effective in reducing substance use with young people who 
had a substance use disorder by using either a single intervention or a multicomponent intervention. These 
interventions included parent training, family communication skills, CBT, social skills training and 
motivational interviewing.96–101 Family communication skills focused on teaching parents and children 
effective ways to engage with each other.100 Three programs were delivered to either young people or their 
families, while one provided individual family sessions and a group for youth.98 Of these four programs, 
Multidimensional Family Therapy stood out by showing positive outcomes in three RCTs, including one 
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Table 4 summarizes the main substance use findings as well as the prevalence for SUDs and the estimated 
number of BC children affected at any given time. The Appendix gives more details on the 16 RCTs 
evaluating substance use disorder interventions. 
 
Table 4. Effective Substance Use Disorder Interventions  
Substance Use Disorders 2.3% or 8,200 (12–18 years) in BC 
Prevention: Multicomponent interventions (10 RCTs in total with 1 RCT evaluating a single component)77–95 
including combinations of child education, cognitive-behavioural therapy, communication skills, motivational 
interviewing, parent training, resistance skills, +/or social skills training  
Treatment (Psychosocial): Multicomponent interventions (6 RCTs in total with 1 RCT evaluating a single 
component)96–101 including combinations of cognitive-behavioural therapy, family communication skills, 
motivational interviewing, parent training +/or social skills training 
 
 




Four targeted cognitive-behavioural therapy (CBT) interventions, evaluated in six RCTs, proved effective in 
reducing depression diagnoses and/or symptoms.102–108 CBT typically involved educating children and 
families about depression, teaching children to challenge unrealistic and unhelpful thinking, and 
encouraging children to engage in more pleasurable and productive activities.109 All CBT programs were 
delivered in groups, two provided to children and one to families. The remaining CBT intervention was a 
book that youth read. These interventions were completed by young people ranging in age from nine to 19 
years. The program Coping with Stress stood out by showing positive outcomes across four RCTs, including 
three that reduced depression diagnoses. Effect sizes were also impressive. For example, in one RCT, two 





A meta-analysis of 52 RCTs found that interpersonal therapy (IPT) and CBT effectively reduced depression 
symptoms in children.110 IPT focused on helping young people make connections between depressive 
symptoms and specific problems such as grief and role transitions, and supporting them to develop 
strategies for addressing these problems.111 Both IPT and CBT were more effective than treatment-as-usual, 
waitlist controls and play therapy at the end of treatment. However, at six- to 12-month follow-up, only IPT 




Fluoxetine effectively reduced mood symptoms for children and youth across four RCTs.112–115 However, 
fluoxetine also produced adverse events including significantly more “suicide-related events” (such as 
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attempts and suicidal thoughts)116 and headaches than placebo.114  
 
Table 5 summarizes the main depression findings as well as the prevalence for depression and the estimated 
number of BC children affected at any given time. The Appendix gives more details on the 10 RCTs and 
the meta-analysis evaluating the depression interventions. 
 
Table 5. Effective Depression Interventions  
Depression 1.3% or 9,700 (4–18 years) in BC 
Prevention: Cognitive-behavioural therapy (6 RCTs)102–108  
Treatment (Psychosocial): Interpersonal therapy + cognitive-behavioural therapy (meta-analysis including 52 
RCTs)110  
Treatment (Medication): Fluoxetine (4 RCTs)112–115 
 
 




Six behavioural and two cognitive-behavioural therapy (CBT) interventions improved core symptoms of 
autism spectrum disorder according to a systematic review of eight RCTs.117 The behavioural interventions 
focused on increasing children’s appropriate engagement in social interactions118–123 while CBT taught 
children skills including taking others’ perspective and adapting their behaviour to different situations.124–125 
Most behavioural interventions involved teaching individual parents skills to use with their children. The 
exception was a computer program for children.123 In comparison, both CBT interventions were delivered 
to groups of children. All interventions focused on younger children, with behavioural interventions 
typically focused on preschoolers and CBT focused on school-age children.   
 
Table 6 summarizes the main autism findings as well as the prevalence for autism spectrum disorder and 
the estimated number of BC children affected at any given time. The Appendix gives more details on the 
systematic review that reported the RCTs.  
 
Table 6. Effective Autism Spectrum Disorder Interventions  
Autism Spectrum Disorder 0.4% or 3,000 (4–18 years) in BC 
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Nine cognitive-behavioural therapy (CBT) interventions proved effective in reducing OCD diagnoses 
and/or symptoms.126–134 CBT typically began by providing children and parents with information about 
OCD, then teaching children anxiety management strategies — such as breathing and relaxation techniques 
— as well as how to challenge unrealistic and unhelpful anxious thinking. Children were also supported to 
confront their obsessions while resisting the urge to engage in compulsions.135 CBT was effective whether it 
was delivered to individual children or individual families, including a version that families completed over 
the internet with only minimal support from a practitioner. CBT was also effective with children between 




Fluoxetine, sertraline, paroxetine and clomipramine proved effective in reducing OCD symptoms based on 
a meta-analysis of 13 RCTs.136 Fluoxetine stood out by showing effectiveness in three RCTs and by having a 
more favourable adverse event profile. In contrast, clomipramine was associated with particularly 
concerning adverse events including serious heart rhythm abnormalities.137 But notably, when compared, 
CBT produced significantly larger treatment effects than any of the medications.136  
 
Table 7 summarizes the main OCD findings as well as the prevalence for OCD and the estimated number 
of BC children affected at any given time. The Appendix gives more details on the nine RCTs and one 
meta-analysis evaluating the OCD interventions. 
 
Table 7. Effective OCD Interventions  
OCD 0.3% or 2,200 (4–18 years) in BC 
Treatment (Psychosocial): Cognitive-behavioural therapy (9 RCTs)126–134  
Treatment (Medication): Fluoxetine, sertraline, paroxetine + clomipramine (1 meta-analysis including on 3 
RCTs for fluoxetine + 2 RCTs for all other medications)136 
 
 




Three multicomponent interventions proved effective in reducing symptoms of bipolar disorder across four 
RCTs.138–141 These interventions included family education, problem-solving and communication training. 
Family education included providing information about bipolar disorder while problem-solving focused on 
identifying problems, brainstorming solutions, then implementing the best of these. Communication 
training involved teaching skills to families including listening actively and providing effective feedback.138, 141 
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Importantly, most young people were also taking medications for their bipolar disorder. Two interventions 





Lithium was effective in reducing bipolar disorder symptoms according to two RCTs.142–143 However, it was 
associated with adverse events including excessive thirst, nausea, vomiting, headache and tremor, among 
others.142–143  
 
Table 8 summarizes the main bipolar findings as well as the prevalence for bipolar disorder and the 
estimated number of BC children affected at any given time. The Appendix gives more details on the six 
RCTs evaluating the bipolar interventions.  
 
Table 8. Effective Bipolar Disorder Interventions  
Bipolar Disorder 0.3% or 1,100 (12–18 years) in BC 
Treatment (Psychosocial): Multicomponent interventions including combinations of communication skills, 
family education + problem-solving (adjunctive to medications in most cases) (4 RCTs)138–141 
Treatment (Medication): Lithium (2 RCTs)142–143 
 
 




Four multicomponent interventions, evaluated in five RCTs, proved effective in reducing symptoms of 
eating disorders, including one universal program and three that were targeted.144–150 Program components 
included discouraging unhealthy weight control practices, such as dieting, and encouraging positive body 
image using strategies such as challenging negative thoughts that young people had about their bodies.146–
147, 150 Additional components included media literacy training — which involved developing skills to 
address an overemphasis on thinness — and implementing a healthy lifestyle plan, including changes to 
food intake and activity levels.144, 149–150 Three programs were delivered to groups of girls, while one was self-





Family therapy resulted in significantly more young people achieving remission from anorexia nervosa at 
follow-up compared with individual child therapy, based on a meta-analysis of three RCTs.151 Family 
therapy focused on helping parents avoid blaming themselves for their child’s eating disorder and helping 
the family develop a plan for restoring the child’s weight through eating meals together — until the child 
was able to take more control over their own eating.152–153 Family therapy also resulted in significantly more 
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young people achieving remission from bulimia nervosa at follow-up compared with individual child 
therapy, based on two RCTs covered in the same meta-analysis.151 Family therapy for bulimia nervosa 
emphasized parental management of children’s eating behaviours.154 
 
Table 9 summarizes the eating disorder findings as well as the prevalence for eating disorders and the 
estimated number of BC children affected at any given time. The Appendix gives more details on the five 
RCTs and one meta-analysis evaluating the eating disorder interventions. 
 
Table 9. Effective Eating Disorder Interventions  
Eating Disorders 0.2% or 700 (12–18 years) in BC 
Prevention: Multicomponent interventions (5 RCTs in total)144–150 including combinations of discouraging 
unhealthy weight control practices, encouraging positive body image, implementing healthy lifestyle plan +/or 
media literacy training 
Treatment (Psychosocial): Family therapy (1 meta-analysis including 5 RCTs)151 
 
 




Four targeted cognitive-behavioural therapy (CBT) interventions, evaluated in five RCTs, proved effective in 
reducing posttraumatic stress symptoms in children who had been maltreated.155–160 CBT typically involved 
teaching children specific skills including recognizing emotions, solving problems and managing anger.155 
Importantly, parents were involved in three of the programs, including being taught ways to support their 
children and improve communications with them.158–160 Two  interventions were delivered in groups and 




Three CBT interventions proved successful in reducing posttraumatic stress disorder (PSTD) symptoms 
and/or diagnoses.161–163 One reduced PTSD diagnoses and symptoms in girls who had been sexually 
abused.162 The other two reduced symptoms for children exposed to a variety of traumas.161, 163 These CBT 
interventions typically included educating children about common reactions to trauma, teaching breathing 
exercises, and helping children to recount their traumatic experiences while being supported.161–162 Two 
interventions were delivered to individual children while one was delivered in groups. Participating children 
ranged from seven to 18 years. 
 
Table 10 summarizes the main PTSD findings as well as the prevalence for PTSD and the estimated 
number of BC children affected at any given time. The Appendix gives more details on the eight RCTs 
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Table 10. Effective PTSD Interventions  
PTSD 0.1% or 700 (4–18 years) in BC 
Prevention: Cognitive-behavioural therapy (5 RCTs, 2 of which also included parent training)144–150  
Treatment (Psychosocial): Cognitive-behavioural therapy (3 RCTs)161–163 
 
 




Aripiprazole and olanzapine were both effective in reducing schizophrenia symptoms according to two 
RCTs each.164–167 However, these medications were associated with adverse events. Sedation and tremors 
were common with aripiprazole, while elevated prolactin levels and weight gain were common with 
olanzapine.165–166  
 
Table 11 summarizes the schizophrenia findings well as the prevalence for schizophrenia and the estimated 
number of BC children affected at any given time. The Appendix gives more details on the four RCTs 
evaluating these medications. 
 
 Table 11. Effective Schizophrenia Interventions  
Schizophrenia 0.1% or 400 (12–18 years) in BC 








Psychosocial interventions can be cost-effective,  
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We found effective prevention interventions for eight of the 12 most common childhood mental disorders 
including anxiety disorders, ADHD, oppositional defiant and conduct disorders, SUDs, depression, eating 
disorders and PTSD. These findings show that there are numerous opportunities to protect children from 
the unnecessary distress and impairment caused by these disorders. Still, despite strong evidence for 
prevention, these kinds of programs receive limited funding in most jurisdictions. In Canada, public health 
spending has constituted only 5.4% of health expenditures overall.168 This suggests there are considerable 
opportunities for further investments in prevention. BC has shown leadership in this area, including 
making significant investments in three prevention programs identified in this review. This includes 
developing CBT resources for teachers, school counsellors and parents to support children with anxiety.169 
BC has also invested in Parent Management Training – Oregon, adapted for local use, called Confident 
Parents: Thriving Kids.169 Finally, Nurse Family Partnership is being evaluated through the BC Healthy 
Connections Project170–171 and is being provided as an enhanced public health service to young first-time 
mothers and their children in four regional health authorities.172  
 
Prevention investments also confer benefits to society as a whole through averted “downstream” costs in the 
healthcare, special education, child protection and justice systems — as well as reducing economic losses 
associated with people’s societal contributions when disorders persist unnecessarily into adulthood.173–174 
For example, preventing a single case of conduct disorder has been estimated to yield lifetime savings of $5–
8 million per child.175 (All figures reflect 2020 CAD values.) Regarding the prevention of behaviour 
disorders more generally, economic returns have been estimated for five successful programs covered in this 
review. Most calculations involve net benefit estimations, which account for both program delivery costs 
and long-term saving across multiple public service sectors — both for participants and for society — such as 
savings resulting from reductions in crime.174 Using this approach, Incredible Years produced returns of 
approximately $9 thousand per child.176 Similarly, the Good Behaviour Game led to net benefits of 
approximately $14 thousand per child176 while Nurse-Family Partnership and Parent Management Training 
led to net benefits of $6 thousand and $8 thousand per child, respectively.176 The estimated benefits of 
Perry Preschool were calculated using a different metric, with estimated returns of approximately $10–23 
dollars for every dollar invested.177 In other words, as well as effectively preventing disorders and/or 
symptoms from arising, these successful programs may pay for themselves by reducing the use of other 
public services over time.176 
 
 
4.2 Psychosocial Treatments 
 
We found effective psychosocial treatments for 11 of the 12 mental disorders covered in this review 
including anxiety, ADHD, oppositional defiant and conduct disorders, SUDs, depression, autism, OCD, 
bipolar disorder, eating disorders and PTSD. Notably, many effective treatments resulted in children 
	
 
Preventing and Treating Childhood Mental Disorders: Effective Interventions Page 21 of 43 




experiencing benefits beyond symptom reductions — including disorder remission. As well, gains were often 
enduring, with 15 interventions — evaluated in 17 RCTs — showing benefits persisting for a year or more 
post-treatment. Also, many treatments were delivered efficiently, in group and self-directed formats, 
allowing more children to be reached.   
 
Several psychosocial treatments had particularly strong evidence of effectiveness, including multiple RCTs 
showing beneficial outcomes and large effect sizes, warranting their use as a first-line treatment. These 
include: CBT for anxiety, PTSD and OCD; parent training for oppositional defiant and conduct disorders; 
IPT for depression; behavioural interventions for autism spectrum disorder; and family therapy for eating 
disorders. Parent training also has evidence of success in helping youth with SUDs as well as helping 
children with ADHD, particularly when combined with an effective medication. Similarly, problem-solving 
and communication skills training may be helpful adjunctively to medication for young people with bipolar 
disorder.    
 
Psychosocial interventions can be cost-effective, in addition to being clinically effective. This has been 
demonstrated through net benefit calculations which account for both program delivery costs and long-term 
saving across multiple public service sectors — for participants and for society. According to estimates from 
such economic evaluations, CBT for childhood anxiety disorders produced a net benefit of approximately 
$14 thousand per child.176 (All figures reflect 2020 CAD values.) Similarly, CBT for childhood OCD 
produced a net benefit of nearly $16 thousand per child.176 Parent training for ADHD produced a net 
benefit of slightly more than $12 thousand per child.176 As well, two programs for oppositional defiant and 
conduct disorders — Multidimensional Treatment Foster Care and Multisystemic Therapy — showed net 
benefits of approximately $43 and $24 thousand per child respectively.176 As well as effectively treating 
children’s symptoms, impairment and distress, these programs may therefore also pay for themselves by 




Medications showed success in treating eight of the 12 disorders covered in this review including anxiety, 
ADHD, oppositional defiant and conduct disorders, depression, OCD, bipolar disorder and schizophrenia. 
However, there is strong evidence that psychosocial interventions alone can suffice for effectively treating 
anxiety, oppositional defiant and conduct disorders, depression and OCD. Psychosocial interventions 
should therefore be offered first for these disorders — and medications only considered after psychosocial 
interventions have been maximized, particularly considering medication side effects. For example, while 
risperidone may reduce symptoms of oppositional defiant and conduct disorders, it can lead to serious 
cardiovascular and endocrine adverse events.137 As well, medications for these disorders do not yield the 
same long-term gains that psychosocial interventions do.  
 
Even for conditions where medications are considered a first-line treatment — such as ADHD, bipolar 
disorder and schizophrenia — risks and benefits must still be carefully weighed. For example, longer-term 
use of methylphenidate and dextroamphetamine has been associated with decreases in children’s height 
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and weight.178 As well, while lithium can address bipolar symptoms, it can also cause renal and endocrine 
problems, among other difficulties, and consequently requires ongoing monitoring.179 Similarly, while 
aripiprazole and olanzapine can address schizophrenia symptoms, both require careful oversight to ensure 
that cardiovascular and other side effects are managed.  
 
There is also a clear need to evaluate medications that are being prescribed to young people — but where 
high-quality studies are lacking.180 For example, young people with opioid use disorders are sometimes 
prescribed suboxone or methadone, even though these drugs have yet to be rigorously evaluated for use in 
youth.181  
 
4.4  Moving Forward  
 
Mental disorders typically start in childhood and cause significant impairment and distress — interfering 
with development and preventing children from flourishing and reaching their potential.182 Beyond the 
hardships that these disorders cause for individual children and families, there are also significant avoidable 
costs for society as a whole.176 Adding to the burdens, without effective prevention or treatment 
interventions early in life, mental disorders often persist into adulthood, causing distress and avoidable 
costs over the lifespan.183–184  
 
Based on 113 randomized controlled trials (RCTs) and six systematic reviews, we identified effective 
prevention interventions for eight of the most common childhood mental disorders and effective 
treatments for all 12. However, estimates from high-quality epidemiological studies indicate that an 
estimated 55.8% of children with mental disorders — or nearly 53,000 children in BC — do not receive 
services for these disorders in a typical year.2 These estimates suggest stark service shortfalls, even apart from 
the question of effective services.  
 
To address these high levels of need, a first step is adopting a comprehensive population health strategy for 
children’s mental health. Such a strategy includes:  
1)  Addressing social determinants and reducing avoidable childhood adversities that contribute to the 
development of mental health problems  
2)  Providing effective prevention programs, such as those reported here, for children at risk 
3)  Providing effective treatments, such as those reported here, for all children with disorders, and  
4)  Monitoring needs and outcomes over time to evaluate and improve intervention efforts.  
 
Vigorous central leadership is also required to ensure that such a plan is sustained over time, accompanied 
by adequate and dedicated children’s mental health budgets, and coordinated across all relevant sectors 
within government. BC’s children will benefit, as will everyone, if children’s mental health is made a high 
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Appendix: Study and Intervention Details  
Anxiety Disorder Evidence*   
Randomized Controlled Trials 
Program  Program elements  Age/Grade Duration Follow-up Anxiety outcomes (Effect sizes) 
Prevention – Universal 
MoodGYM 8 Self-directed child cognitive-
behavoural therapy (CBT)  
12–17 years 1¼ months 6 months ↓ 1 of 1 symptom (d=0.25) 
Prevention – Targeted 
Cool Little Kids G 9 Parent CBT training 4 years 3 months 9 months Î Any diagnoses  
↓ 1 of 1 symptom  
Coping and Promoting 
Strength 10 
Family CBT 7–12 years  5 months 9 months ↓ Any diagnoses 
↓ 2 of 3 symptoms (d=0.82–1.99) 
Coping and Promoting 
Strength 11–12 
Family CBT  6–13 years 5 months 9 months ↓ Any diagnoses (OR=8.54) 
↓ 3 of 4 symptoms (d=0.54–0.74) 
Friends G 13 Child CBT + parent 
education 
Grade 7 5½ months 3¾ years Î Any diagnoses 
↓ 1 of 2 symptoms 
Psychosocial Treatment 
Cool Kids G 15 Child CBT + parent CBT 
training 
7–16 years 2½ months 3 months ↓ Primary diagnoses 
↓ Any diagnoses 
↓ 3 of 6 symptoms 
Cool Little Kids plus Social 
Skills G 16 
Parent CBT training + child 
social skills training 
2–5 years 2½ months 3 months ↓ Any diagnoses 
↓ # of diagnoses (d=1.76) 
↓ 3 of 5 symptoms (d=0.89–2.11) 
Coping Cat 17 Child CBT  7–14 years 4 months  1 year Î Primary diagnoses 
↓ 1 of 8 symptoms 
Coping Cat 18 Child CBT 9–14 years Not 
reported 
1 year ↓ Any diagnoses (OR=3.29) 
↓ 1 of 3 symptoms (OR=2.56) 
Coping Koala G 19 Child CBT + parent CBT 
training 
Grades 3–7 2½ months 2 years ↓ Any diagnoses 
↓ 2 of 6 symptoms 
Friends G 20–21 Child CBT Grades 2–5 5 months 3 months 
 
Î Primary diagnoses 
Î New diagnoses 
2¾ years ↓ 1 of 5 symptoms 
One-Session Treatment 22 Child CBT  7–16 years 3 hours 6 months ↓ Primary diagnoses 
↓ 1 of 6 symptoms 
Parent Education Program G 
23 
Parent CBT training 3–4 years 2½ months 3 years ↓ Any diagnoses 
↓ 2 of 3 symptoms 
Skills for Academic and 
Social Success G 24 
Child CBT + parent + teacher 
education   
Grades 9–11 5 months 4 months ↓ Primary diagnoses 
↓ 2 of 5 symptoms 
Skills for Academic and 
Social Success G 25 
Child CBT + parent + teacher 
education   
Grades 9–11 5 months 3 months ↓ Primary diagnoses (OR=4.89) 
↓ 3 of 5 symptoms (OR=16.21; 
     d=0.38–0.93) 
Strongest Families – Chase 
Worries Away 26 
Self-directed family CBT 
with coaching  
6–12 years 6½ months 5½ months ↓ Any diagnoses (OR=2.51) 
 
Timid to Tiger G 27 Parent CBT training 2–9 years 2½ months 1 year ↓ Primary diagnoses (OR=3.68) 
↓ Any diagnoses (OR=8.50) 
Î 3 of 3 symptoms 
Medication Also sold as  Age Duration Follow-up Anxiety outcomes (Effect sizes) 
Fluoxetine 28 Prozac 7–17 years 3 months none ↓ Primary diagnoses 
↓ 4 of 8 symptoms 
Fluoxetine 29 Prozac 7–17 years 3 months none ↓ 1 of 6 symptoms 
Sertraline 30 Zoloft 5–17 years 2¼ months none ↓ 6 of 7 symptoms  
Sertraline 31 Zoloft 7–17 years 3 months none ↓ 2 of 2 symptoms (OR=3.9; 
     g=0.45) 
*Anxiety outcomes included two different sources, including at least one that was blinded; for prevention and psychosocial treatment studies, 
postintervention follow-up was 3 months or more.     ↓ Outcome was statistically significant     d = Cohen’s d      G = Group delivery          
Î Outcome was not statistically significant       OR = Odds ratio      g = Hedges’ g      
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Attention-Deficit/Hyperactivity Disorder (ADHD) Evidence* 
Randomized Controlled Trials   
Program  Program elements Age/Grade Duration Follow-up ADHD outcomes (Effect sizes) 
Prevention – Targeted 
Incredible Years G 32 Parent Training (PT) 3–4 years 3 months 3 months ↓ 1 of 1 symptom 
Incredible Years + Literacy 
training G 33–34 
PT  5–6 years 6½ months 4 months ↓ 1 of 1 symptom 
Legacy for Children G 35–36 PT Prenatal 3¼ years 2 years ↓ 1 of 1 symptom (OR=0.50) 
SAFE Children G 37–38 PT + child tutoring  6 years 5 months 4¼ years ↓ 1 of 6 symptoms 
Psychosocial Treatment 
Behavioural and Social 
Skills Class G 42 
Child behaviour 
therapy (BT) + social 
skills training (SST) + 
PT 
5–12 years 1¾ months 3 months ↓ 1 of 2 symptoms 
Child Social Skills and 
Parenting Group G 43 
Child BT + SST + PT 8–10 years 1¾ months  3–4 months ↓ 1 of 2 symptoms (d=0.76) 
New Forest Parenting 
Programme 40 
PT  3–7 years 2¾ months 8¼ months ↓ 1 of 3 symptoms (d=0.25)   
Parenting Group G 41 PT  5–18 years 3 months 1 year ↓ 1 of 5 symptoms 
Strongest Families – 
Parenting the Active Child 
26 
Self-directed PT  8–12 years 3 months 5 months ↓ ADHD diagnosis (OR=2.74) 
Medication Also sold as Age Duration Follow-up ADHD outcomes (Effect sizes) 
Methylphenidate 185  Concerta 8–17 years 1¾ months  none ↓ 3 of 3 symptoms (d=0.23–0.52) 
Methylphenidate 186 Concerta 6–12 years ¾ month none ↓ 3 of 3 symptoms  
Systematic Reviews  
Medication 
Methylphenidate, dextroamphetamine and atomoxetine were effective in significantly reducing ADHD symptoms. All produced similar side 
effects. Cost-effectiveness analysis favoured methylphenidate and dextroamphetamine given that these medications were less expensive while 
being as effective as atomoxetine based on 64 RCTs.44  
Medication and Psychosocial Treatment 
Methylphenidate, alone or combined with psychosocial treatments, were significantly more effective than psychosocial treatments alone at end 
of treatment based on 26 RCTs. The effect sizes were largest for combined treatments (d=1.77–1.89) compared to medications alone (d=1.53–
1.83) and psychosocial alone (d=0.75–0.87) based on parent and teacher ratings.45  
*ADHD prevention outcomes included one source while psychosocial treatment outcomes included two differences sources, including at least 
one that was blinded; for prevention and psychosocial treatment studies, postintervention follow-up was 3 months or more.      
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Conduct and Oppositional Defiant Disorder Evidence*  
Randomized Controlled Trials   
Program  Program elements Age/Grade Duration Follow-up Behaviour outcomes (Effect sizes) 
Prevention – Universal 
Good Behavior Game G 60 Child behaviour 
therapy (BT) 
Grade 1 2 school years 14 years ↓ Antisocial personality diagnoses 
Triple P G 46–47 Parent training (PT) 3–6 years 1 month 4 years ↓ 2 of 8 symptoms 
Triple P G 48–49 PT Grade 1 1 month 8 years ↓ 2 of 7 symptoms (d=0.11–0.15) 
Prevention – Targeted 
Chicago Parent Program G 50 PT 2–4 years  2¾ months 1 year ↓ 2 of 4 symptoms 
Classroom-Centred 
Intervention G 61–62 
Child social skills 
training (SST), BT + 
enriched curricula 
Grade 1 1 school year 5 years ↓ Conduct diagnoses (OR=0.42) 
5–11 years ↓ 1 of 1 symptom 
Family School Partnership G 
61–62 
PT + parent-school 
collaboration  
Grade 1 1 school year 5 years Î Conduct diagnoses 
5–11 years ↓ 1 of 1 symptom 
Fast Track G 63–64 PT, child SST+ 
tutoring   
Grade 1 10 school 
years   
8 years ↓ Antisocial personality diagnoses  
(OR=0.60) 
↓ 2 of 5 symptoms 
Incredible Years Basic G 51 PT  3–4 years 2¾ months 3¼ months ↓ 2 of 4 symptoms (d=0.63–0.89) 
Incredible Years Enhanced G 
52 
PT 2–5 years 9–11 months 8 months ↓ 1 of 2 symptoms 
Nurse Family Partnership 53 PT Prenatal 2¼ years 13 years ↓ 3 of 14 symptoms 
Parent-Management 
Training – Oregon G ♂ 54 
PT 6–10 years 3¼ months 8¾ years ↓ 3 of 3 symptoms (d=0.28) 
Perry Preschool G 65 Parent school 
collaboration + 
enriched curricula 
3–4 years 1¼ years  35 years ↓ 2 of 9 symptoms (OR=0.48–0.54) 
Strongest Families Smart 
Website 55–56 
Self-directed PT with 
coaching  
4 years 10 months 1¼ years ↓ 1 of 2 symptoms (d=0.22) 
Triple P Online 57 Self-directed PT with 
coaching  
2–8 years 4 months 5 months ↓ 2 of 3 symptoms (d=0.70–1.28) 
Triple P Online Brief 58 Self-directed PT  2–9 years 2 months 9 months ↓ 2 of 4 symptoms (d=0.39–0.41) 
Psychosocial Treatment  
Brief Intervention 69 Child cognitive-
behavioural therapy 
(CBT) 
11–17 years ½ month 2 years ↓ 1 of 1 symptom 
Incredible Years Basic G 66–67 PT 3–7 years 3–3¾ months 7¾ years ↓ Oppositional defiant diagnoses  
(OR=0.20) 
↓ 1 of 3 symptoms 
Multidimensional Treatment 
Foster Care G ♂ 70–71 
PT + child SST   12–17 years 6¾ months 1½ years ↓ 2 of 2 symptoms 
Multidimensional Treatment 
Foster Care G ♀ 72 
PT+ child SST  13–17 years 5¾ months 1½ years ↓ 1 of 3 symptoms 
Multitsystemic Therapy ♂ 73 PT + child CBT  11–17 years 7 months 1½ years ↓ 1 of 2 symptoms (OR=0.41) 
Parent-Child Interaction 
Therapy 68 
PT  2–7 years 5 months 1 year ↓ 2 of 5 symptoms (d=0.61–0.64) 
Medication Also sold as Age Duration Follow-up Behaviour outcomes 
Risperidone 74 Risperdal  12–18 years  1½ months none ↓ 1 of 3 symptoms 
Risperidone 75 Risperdal  6–14 years  2½ months none ↓ 5 of 6 symptoms 
Risperidone 76 Risperdal  5–12 years  1½ months none ↓ 3 of 3 symptoms 
*Behaviour outcomes included two different sources, including at least one that was blinded; for prevention and psychosocial treatment 
studies, postintervention follow-up was 3 months or more.     G = Group delivery      ↓ Outcome was statistically significant      d = Cohen’s d      
OR = Odds ratio     Î Outcome was not statistically significant      ♂ = Boys only      ♀ = Girls only  
	
 
Preventing and Treating Childhood Mental Disorders: Effective Interventions Page 38 of 43 










Substance Use Disorder Evidence* 
Randomized Controlled Trials   
Program  Program elements Age/Grade Duration Follow-up Substance use outcomes  
(Effect sizes) 
Prevention – Universal 
Iowa Strengthening Families 
G 77 
Parent training (PT) + child 
resistance skills 
Grade 6 1½ months  9 years ↓ 2 of 4 symptoms (RRR=19%–
21%) 
Life Skills Training G 78–79 Child social skill training 
(SST) + resistance skills 
Grade 7 1¾ school 
years 
1 year ↓ 2 of 5 symptoms 
Preparing for the Drug Free 
Years G 77, 80 
PT + child resistance skills Grade 6 1¼ months 9–10 years ↓ 1 of 5 symptoms (RRR=11%) 
Project PATHS G 81–83 Child communication skills 
+ SST 
Grades 7–9 3 school 
years 
2 years ↓ 6 of 7 symptoms 
Substance Use Prevention 
for Girls ♀ 84 
Self-directed child 
communication skills + 
resistance skills + PT 
11–13 years 2¼ months 1 year ↓ 3 of 3 symptoms 




2¾ months 1¼ years ↓ 2 of 4 symptoms (OR=0.62–    
    0.80) 
Unplugged G 86 Child education + resistance 
skills  
Grade 6 1 school 
year 
2 years ↓ 1 of 5 symptoms (OR=0.56) 
Prevention – Targeted 
CHAT 90 Child motivational 
interviewing (MI) 
12–18 years 15 minutes 1 year ↓ 2 of 7 symptoms 
Middle School Success G ♀ 88 Child SST + coaching + 
caregiver training 
10–12 years 1 year 2 years ↓ 1 of 2 symptoms (d=0.57) 
Preventure G 91–92 Child education, MI + 
cognitive-behavioural therapy 
(CBT) 
Grades 8–10 ½ month   2 years ↓ 3 of 5 symptoms (d=0.18–0.25) 




Child MI + CBT  14–19 years ½ month 3 months ↓ 3 of 3 symptoms (d=0.22–0.71) 
Brief Intervention 97 Child MI  Grade 9–12 ½ month  6 months ↓ 4 of 5 symptoms 
Child MI + PT Grade 9–12 ¾ month  6 months ↓ 2 of 5 symptoms 
Integrated Family + 
Cognitive-Behavioural 
Therapy G 98 
Family communication skills, 
PT + child CBT 
14–18 years 3¾ months 6 months ↓ 2 of 3 symptoms   
Multidimensional Family 
Therapy 99   
Family communication 
skills, PT + Child SST  
13–18 years 6 months 6 months ↓ 1 of 3 symptoms (d=1.66) 
Multidimensional Family 
Therapy 100  
Family communication 
skills, PT + Child SST  
12–17 years 4–6 months 1 year ↓ 3 of 6 symptoms (d=0.32–0.59) 
Multidimensional Family 
Therapy 101  
Family communication 
skills, PT + Child SST  
11–15 years 3–4 months 8¼ months ↓ 3 of 5 symptoms (d=0.77–1.36; 
OR=2.20) 
*SUD outcomes included one source; for prevention studies, postintervention follow-up was 1 year or more; for treatment studies, 
postintervention follow-up was 3 months or more; for universal prevention programs, all interventions were delivered in schools.       
G = Group delivery     ↓ Outcome was statistically significant     RRR = Relative risk reduction     ♀ = Girls only     OR = Odds ratio        
d = Cohen’s d      
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Depression Evidence*   
Randomized Controlled Trials   
Program  Program elements Age/Grade Duration Follow-up Mood outcomes (Effect sizes) 
Prevention – Targeted  
Coping with Stress G 102  Child cognitive-behavioural 
therapy (CBT) 
Grades 9–10 1¼ months  1 year ↓ depression/dysthymia diagnoses 
Î 4 of 4 symptoms 
Coping with Stress G 103 Child CBT + parent 
education 
13–18 years 3½ months 2 years Î depression diagnoses 
↓ 4 of 6 symptoms 
Coping with Stress G 104 Child CBT 14–19 years 1½ months 4½ months ↓ depression diagnoses (OR=2.5) 
↓ 2 of 2 symptoms (d=0.39–0.42) 
Coping with Stress G 105–106   Child CBT 13–19 years 1½ months 2 years ↓ depression diagnoses (HR=2.48) 
Family Group CBT G 107 Family CBT 9–15 years 2¾ months 1½ years ↓ depression diagnoses (OR=2.91) 
Î1 of 1 symptom 
Feeling Good 104 CBT book 14–19 years 1½ months 4½ months ↓ depression diagnoses (OR=4.5) 
↓ 1 of 2 symptoms (d=0.28) 
Icelandic Prevention G 108 Child CBT 14–15 years 2½ months 1 year ↓ depression/dysthymia  
    diagnoses (HR=0.18) 
Systematic Review 
Psychosocial Treatment  
Interpersonal Therapy (IPT) and CBT were the only psychotherapies among the nine assessed that were significantly more effective than most 
comparison conditions at the end of treatment and follow-up based on 52 RCTs. IPT produced slightly larger effect sizes than CBT at both 
end of treatment and at follow-up (IPT Surface under the cumulative ranking curve at post-test=90.5%; at follow-up=90.3%).110 
Randomized Controlled Trials   
Medication Also sold as Age Duration Follow-up Mood outcomes (Effect sizes) 
Fluoxetine 112 Prozac 12–17 years 2¾ months none ↓ 3 of 7 symptoms 
Fluoxetine 113 Prozac 7–17 years 1¾ months none ↓ 2 of 4 symptoms 
Fluoxetine 114 Prozac 8–17 years 2 months  none ↓ 4 of 5 symptoms (d=0.31–0.54)  
Fluoxetine 115 Prozac 13–19 years 3¾ months none ↓ 1 of 2 symptoms (g=0.78) 
*Mood outcomes included two different sources, including at least one that was blinded; for prevention and psychosocial treatment studies, 
postintervention follow-up was 3 months or more and included diagnostic outcomes.     G = Group delivery     ↓ Outcome was statistically 




Autism Spectrum Disorder Evidence   
Systematic Review  
Psychosocial Treatment 
Behavioural and cognitive-behavioural interventions with preschool and school-age children produced improvements in communication, 
socialization and adaptive behaviour based on eight RCTs contained in a systematic review (SR). Five behavioural programs taught parents 
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Obsessive-Compulsive Disorder (OCD) Evidence*   
Randomized Controlled Trials 
Program  Program elements Age Duration Follow-up OCD outcomes (Effect size) 
Psychosocial Treatment 
Cognitive-Behavioural 
Therapy (CBT) 126  
Child CBT  9–18 years 3 months   none ↓ 1 of 2 symptoms (d=1.07) 
CBT 127   Child CBT  10–18 years 3 months none ↓ OCD diagnosis 
↓ 4 of 4 symptoms (d=1.6–2.2) 
CBT + Positive Family 
Interaction Therapy † 134  
Child CBT + family 
education + problem-solving 
8–17 years  2¾ months   none ↓ 2 of 3 symptoms (φ=0.28) 
Family-based CBT 129  Family CBT 3–8 years 1½ months none ↓ 5 of 5 symptoms (d=1.24–1.69)  
Family-based CBT 130  Family CBT  5–8 years 3¼ months  none ↓ 3 of 4 symptoms (d=0.31–0.84) 
Family-based CBT 132   Family CBT  8–17 years 3¼ months none ↓ 1 of 4 symptoms 
Internet-Delivered Family 
CBT 131  
Family CBT  7–16 years 2¾ months  none ↓ 5 of 5 symptoms (η2=0.16–0.44)  
Internet-Delivered Family 
CBT 133  
Self-directed family CBT 
with coaching 
12–17 years 2¾ months none ↓ 6 of 7 symptoms (d=0.69) 
Telephone-Delivered CBT** 
128 
Child CBT 11–18 years 4 months  1 year ↓ 2 of 3 symptoms 
Systematic Review 
Psychosocial Treatment and Medication 
CBT produced significantly larger treatment effects (d =1.45) than the medications fluoxetine, sertraline, paroxetine and clomipramine 
(average d = 0.48) based on 13 RCTs, of which 5 evaluated CBT. Among the medications, fluoxetine and sertraline had moderate effect sizes 
(d = 0.51 and 0.47) and the most favourable adverse event profiles.136 
 
*OCD outcomes included two different sources, included at least one that was blinded   ↓ Outcome was statistically significant        
d = Cohen’s d       † Limited to children from families with 2+ indicators of poor family functioning associated with diminished response to 
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Bipolar Evidence*  
Randomized Control Trials   
Program  Program elements Age Duration Follow-up Bipolar outcomes (Effect size)  
Psychosocial Treatment** 
Child- and Family-Focused 
Cognitive-Behavioural 
Therapy (CBT) 139 
Family education, 
problem-solving, 
communication skills + 
CBT 
7–13 years 9 months none ↓ 2 of 5 symptoms† (d=0.48–0.50) 
Family-Focused Therapy 140 Family education, 
problem-solving, + 
communication skills 
12–17 years 9 months 1¼ years ↓ 1 of 2 symptoms† 
Family-Focused Therapy 141 Family education, 
problem-solving, + 
communication skills 
9–17 years 4 months 8 months ↓ 1 of 2 symptoms (d=0.49)  
Multifamily 
Psychoeducational 




8–11 years 1¾ months 10 months ↓ 1 of 1 symptom 
Medication Also sold as Ages Duration Follow-up Bipolar outcomes (Effect size) 
Lithium 142 Carbolith 12–18 years 1½ months  none ↓ 1 of 2 symptoms† 
Lithium 143 Carbolith 7–17 years 1¾ months none ↓ 2 of 5 symptoms (d=0.53) 
*Bipolar outcomes included at least one blinded measure; outcomes included manic or hypomanic symptoms; studies with insufficient 
statistical power or inappropriate analyses were excluded.     ** Psychosocial treatments were adjunctive to medications in most cases      
↓ Outcome was statistically significant     † None of the significant outcomes included reductions in manic or hypomanic symptoms.       
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Eating Disorders Evidence*   
Randomized Control Trials   
Program  Program elements  Age/Grade Duration Follow-up Eating disorder outcomes 
(Effect size) 
Prevention – Universal 
Education Program G ♀ 144 Media literacy training, 
discouraging unhealthy 
weight control practices + 
encouraging positive body 
image 
Grades 11–12 1½ months 10 months Î Anorexia diagnoses 
↓  Bulimia diagnoses 
↓  2 of 5 symptoms 
Prevention – Targeted 
Dissonance G ♀ 145–146 Discouraging unhealthy 
weight control practices + 
encouraging positive body 
image 
14–19 years 3 weeks 3 years ↓ 3 of 6 symptoms 
   (d=0.19–0.43; HR=2.50) 
Dissonance G ♀ 147–148 
 
Discouraging unhealthy 
weight control practices + 
encouraging positive body 
image 
14–19 years 1 month 3 years Î Eating disorder diagnoses 
↓ 1 of 5 symptoms (d=0.30) 
Healthy Weight G ♀ 149 Discouraging unhealthy 
weight control practices + 
implementing healthy lifestyle 
plan 
14–19 years 3 weeks 1 year ↓ 3 of 4 symptoms 
 
Healthy Weight G ♀ 145–146 Discouraging unhealthy 
weight control practices + 
implementing healthy lifestyle 
plan 
14–19 years 3 weeks 3 years ↓ 5 of 6 symptoms (d=0.08–0.28; 
HR=2.27–2.75) 
Student Bodies 150 Self-directed media literacy 
training, discouraging 
unhealthy weight control 
practices + encouraging 
positive body image 
14–18 years 3¾ months 5 months ↓ 2 of 4 symptoms 
Systematic Review  
Psychosocial Treatments 
Family therapy resulted in significantly more young people achieving remission from anorexia nervosa at follow-up (ranging from 6–12 
months) than individual therapy despite no group difference at end of treatment based on 3 RCTs. Family therapy similarly resulted in 
significantly more young people achieving remission from bulimia nervosa at follow-up (ranging from 6–12 months) than individual therapy 
despite no group difference at end of treatment based on 2 RCTs.151 
*Eating disorder prevention outcomes included two different sources, including at least one that was blinded; For prevention studies, 
postintervention follow-up was 3 months or more.      G = Group delivery     ♀ = Girls only     Î Outcome was not statistically significant        












Preventing and Treating Childhood Mental Disorders: Effective Interventions Page 43 of 43 
© Children’s Health Policy Centre, Faculty of Health Sciences, Simon Fraser University, 2020 
Posttraumatic Stress Disorder (PTSD) Evidence*  
Randomized Controlled Trials 
Program Program elements Age Duration Follow-up PTSD outcomes (Effect size) 
Prevention – Targeted 
Fostering Healthy Futures G 
155–156
Child cognitive-behavioural 
therapy (CBT) + mentoring  
9–11 years 9 months 6 months ↓ 2 of 3 symptoms (d=0.39–0.51) 
Fostering Healthy Futures G 
157 
CBT + mentoring 9–11 years 9 months 6 months ↓ 3 of 3 symptoms (d=0.20–0.29) 
It’s My Turn Now G 158 Child CBT + Parent 
Training (PT)  
6–12 years 2¼ months 6 months ↓ 1 of 2 symptoms 
Multisystemic Therapy 159 Child CBT + PT 10–17 years 8 months 4 months ↓ 3 of 6 symptoms (d=0.55–0.73) 
Risk Reduction through 
Family Therapy 160 
Child CBT + family 
problem-solving 
13–17 years  7¾ months 6 months ↓ 1 of 2 symptoms 
Psychosocial Treatment 
KIDNET G 163 Child CBT 7–16 years 1¾ months 4¼ months ↓ 4 of 5 symptoms 
Prolonged Exposure 
Therapy 161 
Child CBT 12–18 years 3½ months 6 months ↓ 2 of 2 symptoms (d=0.51–0.55) 
Prolonged Exposure 
Therapy ♀ 162 
Child CBT 13–18 years 3¼ months 1 year ↓ PTSD diagnoses 
↓ 3 of 3 symptoms (d=0.81) 
*PTSD outcomes included two different sources, included at least one that was blinded for treatment studies; postintervention follow-up was 3
months or more.  G = Group delivery      ↓ Outcome was statistically significant     d = Cohen’s d     ♀ = Girls only 
Schizophrenia Evidence* 
Randomized Control Trials 
Medication Also sold as Age Duration Follow-up Psychosis outcomes 
(Effect size) 
Aripiprazole 164 Abilify 13–17 years 1½ months none ↓ 6 of 7 symptoms 
Aripiprazole (vs quetiapine) 
165
Abilify 12–17 years 2¾ months none ↓ 1 of 1 symptom** 
Olanzapine 166 Zyprexa 13–17 years 1½ months none ↓ 5 of 6 symptoms 
Olanzapine (vs clozapine) 167 Zyprexa 7–16 years 1¾ months none ↓ 3 of 5 symptoms** (d=0.6–
     1.3) 
*Schizophrenia outcomes included at least one blinded measure; head-to-head trials were accepted if at least one medication was already
established as being effective in a placebo-controlled RCT with young people; studies with insufficient statistical power or inappropriate
analyses were excluded.     ↓ Outcome was statistically significant     ** For head-to-head trials, reported outcomes are time effects.
d = Cohen’s d
